Bioavailability/Bioequivalence Joint Venture Set Up

The value of Indonesia's US$190mn pharmaceutical export sector is set to grow in light of the formation of a joint venture that will test medicines for quality - a vital requirement for purchasers in developed markets. BMI forecasts that foreign sales of Indonesian-made drugs will reach US$283mn by 2013, representing a compound annual growth rate (CAGR) of

To read the full article, please choose one of the following options: